-
Je něco špatně v tomto záznamu ?
Fluconazole treatment hyperpolarizes the plasma membrane of Candida cells
H. Elicharova, H. Sychrova,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
- MeSH
- antifungální látky farmakologie MeSH
- buněčná membrána účinky léků fyziologie MeSH
- Candida účinky léků MeSH
- cytosol chemie MeSH
- flukonazol farmakologie MeSH
- lithium toxicita MeSH
- membránové potenciály účinky léků MeSH
- osmotický tlak MeSH
- sodík toxicita MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
Five pathogenic Candida species were compared in terms of their osmotolerance, tolerance to toxic sodium and lithium cations, and resistance to fluconazole. The species not only differed, in general, in their tolerance to high osmotic pressure (C. albicans and C. parapsilosis being the most osmotolerant) but exhibited distinct sensitivities to toxic sodium and lithium cations, with C. parapsilosis and C. tropicalis being very tolerant but C. krusei and C. dubliniensis sensitive to LiCl. The treatment of both fluconazole-susceptible (C. albicans and C. parapsilosis) and fluconazole-resistant (C. dubliniensis, C. krusei and C. tropicalis) growing cells with subinhibitory concentrations of fluconazole resulted in substantially elevated intracellular Na(+) levels. Using a diS-C3(3) assay, for the first time, to monitor the relative membrane potential (ΔΨ) of Candida cells, we show that the fluconazole treatment of growing cells of all five species results in a substantial hyperpolarization of their plasma membranes, which is responsible for an increased non-specific transport of toxic alkali metal cations and other cationic drugs (e.g., hygromycin B). Thus, the combination of relatively low doses of fluconazole and drugs, whose import into the tested Candida strains is driven by the cell membrane potential, might be especially potent in terms of its ability to inhibit the growth of or even kill various Candida species.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14064207
- 003
- CZ-PrNML
- 005
- 20140709124243.0
- 007
- ta
- 008
- 140704s2013 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3109/13693786.2013.779038 $2 doi
- 035 __
- $a (PubMed)23547882
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Elicharova, Hana $u Department of Membrane Transport, Institute of Physiology Academy of Sciences of the Czech Republic , Prague , Czech Republic.
- 245 10
- $a Fluconazole treatment hyperpolarizes the plasma membrane of Candida cells / $c H. Elicharova, H. Sychrova,
- 520 9_
- $a Five pathogenic Candida species were compared in terms of their osmotolerance, tolerance to toxic sodium and lithium cations, and resistance to fluconazole. The species not only differed, in general, in their tolerance to high osmotic pressure (C. albicans and C. parapsilosis being the most osmotolerant) but exhibited distinct sensitivities to toxic sodium and lithium cations, with C. parapsilosis and C. tropicalis being very tolerant but C. krusei and C. dubliniensis sensitive to LiCl. The treatment of both fluconazole-susceptible (C. albicans and C. parapsilosis) and fluconazole-resistant (C. dubliniensis, C. krusei and C. tropicalis) growing cells with subinhibitory concentrations of fluconazole resulted in substantially elevated intracellular Na(+) levels. Using a diS-C3(3) assay, for the first time, to monitor the relative membrane potential (ΔΨ) of Candida cells, we show that the fluconazole treatment of growing cells of all five species results in a substantial hyperpolarization of their plasma membranes, which is responsible for an increased non-specific transport of toxic alkali metal cations and other cationic drugs (e.g., hygromycin B). Thus, the combination of relatively low doses of fluconazole and drugs, whose import into the tested Candida strains is driven by the cell membrane potential, might be especially potent in terms of its ability to inhibit the growth of or even kill various Candida species.
- 650 _2
- $a antifungální látky $x farmakologie $7 D000935
- 650 _2
- $a Candida $x účinky léků $7 D002175
- 650 _2
- $a buněčná membrána $x účinky léků $x fyziologie $7 D002462
- 650 _2
- $a cytosol $x chemie $7 D003600
- 650 _2
- $a flukonazol $x farmakologie $7 D015725
- 650 _2
- $a lithium $x toxicita $7 D008094
- 650 _2
- $a membránové potenciály $x účinky léků $7 D008564
- 650 _2
- $a osmotický tlak $7 D009997
- 650 _2
- $a sodík $x toxicita $7 D012964
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Sychrova, Hana
- 773 0_
- $w MED00005131 $t Medical mycology $x 1460-2709 $g Roč. 51, č. 8 (2013), s. 785-94
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23547882 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140704 $b ABA008
- 991 __
- $a 20140709124535 $b ABA008
- 999 __
- $a ok $b bmc $g 1031691 $s 862939
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 51 $c 8 $d 785-94 $i 1460-2709 $m Medical mycology $n Med Mycol $x MED00005131
- LZP __
- $a Pubmed-20140704